%0 Journal Article
%T Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study
%A Bo Zhao
%A Jia-yan Chen
%A Meng-meng Su
%A Ming Cui
%A Ming-wei Ma
%A Mu Xie
%A Qing Liu
%A Shang-bin Qin
%A Xian-shu Gao
%A Xiao-bin Gu
%A Xiao-ying Li
%A Xin Qi
%A Xiu-bo Qin
%A Yun Bai
%J Archive of "OncoTargets and therapy".
%D 2018
%R 10.2147/OTT.S159538
%X Bulky non-small cell lung cancer (NSCLC) is difficult to achieve effective local control by conventionally fractionated radiotherapy (CRT). The present work aims to evaluate the safety and efficacy of partial stereotactic ablative boost radiotherapy (P-SABR) in bulky NSCLC
%K P-SABR
%K radiotherapy
%K NSCLC
%K bulky mass
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951217/